Spring 2013
Vol. 26, No. 2

Population Health
Matters
Quarterly Publication
formerly Health Policy Newsletter

GUEST EDITORIAL

Introduction to Personalized Medicine................... 1

Introduction to Personalized Medicine
Readers may have noticed a new
healthcare catchphrase gracing magazine
covers and even the front page of the New
York Times: “personalized medicine.”1 But
what does it mean and how will it change
healthcare? According to the President’s
Council of Advisors on Science and
Technology, ‘Personalized medicine refers
to the tailoring of medical treatment to the
individual characteristics of each patient.’2
Personalized medicine is important
because of several emerging clinical and
financial trends in healthcare. As a result,
there is a strong impetus for personalized
medicine, which can succeed if we can
find a way to break down the silos that
have traditionally separated clinical and
financial world views.
The clinical trends important to
personalized medicine are evidencebased medicine, the genomic revolution,
and big data. Evidence-based medicine
is behind the push to reduce variation in
care, making providers accountable for
delivering treatments that are grounded
in scientific evidence. The genomic
revolution refers to our ability to quickly
and cheaply sequence the human genome
and to determine the biological basis of
behavior and disease. Big data refers to
our ability to create large data sets and

implement automated systems, like IBM’s
Watson, to sort through and make sense of
all the information we collect.
Personalized medicine also capitalizes on
emerging financial trends in healthcare–
pay for performance, bundled payments,
and expansion of affordable care. Pay for
performance is where the rubber meets
the road for evidence based healthcare–no
outcome, no income. Bundled payments
refers to the recognition that medical care,
like a hospitalization for a heart attack,
should be paid for in a lump sum rather
than as separate line item bills for the
hospital stay, EKGs, and aspirin. The need
to deliver affordable care is at the heart
of Affordable Care Act, which aims to
expand health insurance coverage to the
uninsured by finding savings in other parts
of the healthcare system.
Personalized medicine ties together the
clinical trends of evidence-based medicine,
the genomic revolution, and big data with
the financial trends of pay for performance,
bundled payments, and expansion of
affordable care. Evidence-based medicine
gives payers reassurance that individuals
are getting the most appropriate treatment
based on published guidelines. Payment
rates for the expected cost of an entire
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course of care should be as personalized
as the treatments they finance, to ensure
that provider compensation is adequate and
provides the correct incentives–that will
require smart bundled payments. Providers
will collect data on their patients, compare
outcomes to those in the published
literature to benchmark their performance,
and researchers can use the same data to
refine the published literature on outcomes
and costs for this population, i.e. big data.
Payers could use the same data to provide
extra incentives for high-performance
care as demonstrated through superior
outcomes, which is the goal of pay for
performance. This process will ultimately
save costs for patients and allow us to
sustainably cover the entire population
with health insurance, the essence of
affordable care.
So what’s the problem? In our current
fragmented, fee-for-service medical
system, the vision I outlined has yet to
become a reality. Personalized medicine
is a bundled product. However, payers
often pay for each diagnostic, drug, and
device separately. We all know that the
informatics needed to connect a diagnostic
to the therapy regimen and outcomes
just doesn’t exist in most healthcare
environments. Finally, payers are wary
of the idea of paying more upfront for a
new technology that promises savings in
the future—they are more comfortable
focusing on the cost savings in the here
and now by denying reimbursement
for a new test outright, requiring prior
authorizations, or a high degree of patient
cost sharing in order to contain costs.
So what’s the solution? Well, we could
wait for the integrated, affordable

healthcare system of our dreams. If we
are talking about today, however, and
not the year 2100, the answer is to take
a more integrated perspective. What
will get payers to agree to pay for a new
technology when technology has been at
the heart of our cost containment crisis?
Data that shows that personalized medicine
can save costs by avoiding treatments that
will not work. What will get providers to
order those tests, and then actually use
the results? Properly designed incentives
that compare the expected outcomes
and costs of care with patients’ actual
experience. Patients will also need to be
convinced of the need to become involved
in personalized treatment decisions. Highdeductible cost sharing and opaque prices
mean that patients are getting tired of
being surprised with large bills for care
that they consider necessary. The promise
of personalized medicine rests on the
ability of scientists and financial analysts
to collaborate to deliver this critical
information in an impactful way.
I have seen these issues play out on the
ground level in my own research. In one
recent study, funded by MDxHealth,
I was part of a team that investigated
the potential cost savings from a new
technology for the problem of unnecessary
prostate biopsies.3 MDxHealth’s product,
ConfirmDx for prostate cancer, is designed
to reduce the cost associated with repeat
biopsies to diagnose prostate cancer.
Using a budget impact model, we found
that there was the potential for the test
to be cost saving when accounting for
the costs of repeated biopsies and the
costs of the side effects of this invasive
diagnostic procedure. However, the
potential for cost savings were limited by

the need to conform to the one-year time
horizon common in U.S. managed care.
In addition, prospective trials that collect
clinical and financial data on the outcomes
and cost of care will be needed to convince
payers and providers that our results are
credible. New payment models are needed
to correctly align the incentives of patients,
providers, and payers so that the individual
responsible for the cost of care shares in
the benefits of any cost savings.
While there are barriers to studying and
implementing personalized medicine, the
underlying forces motivating this new
platform for healthcare are even stronger.
The questions of how much technology
should cost, who should pay, and the
value of any new technology have taken
on a heightened significance in the age of
tighter budgets. Personalized medicine
holds the promise of moving from a world
of reducing waste on average to reducing
waste on a patient-by-patient basis,
which means a much greater potential for
savings. In order to realize this vision, it
will be necessary to collect both clinical
and financial evidence in order to make the
case for personalized medicine. We can
then achieve our goals of treating patients
as individuals, and doing so at a price we
can afford. 
Robert D. Lieberthal, PhD
Assistant Professor
Jefferson School of Population Health
Robert.Lieberthal@jefferson.edu
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The Untold Story of Population Health
Health is a personal and intimate experience
shared through conversations with our
doctors, family and friends, not merely a
collection of facts and figures. A discussion
about shrinking health care costs or expanding
coverage inevitably leads to a story about
a great doctor, a bad outcome or a serious
disease. We have a need to share our pain, our
fears and our relief about illnesses treated and
cured. People don’t tell stories about the times
when nothing happens or goes wrong.
I began my career as a podiatrist specializing
in the care of the lower-extremity
complications of diabetes and vascular
disease. I treated infections and gangrene, and
often had to cut away dead tissue in the hopes
of avoiding limb loss. My patients suffered
from the largely avoidable complications of
preventable diseases. They were the flesh and
blood evidence of the failure of a system that
devotes little of its considerable resources to
preventing disease—and provides more “sick
care” than health care. In frustration, I looked
upstream to find the causes and rediscovered
public health and population health. I learned
that many people are trying to rewrite the
story of health in our nation so that it begins
with “happily ever after.” More are joining us
every day as the nation realizes there is not
enough money in the US Treasury to treat
every illness that could have been prevented.
Now I teach population health to graduate
students, most of whom are full-time clinicians
or other types of health care professionals. For
many, it’s a hard concept to grasp because they
are trained to see health through the lens of
patient encounters. Population health is more
about what’s not seen, what didn’t happen,
and persons unknown. It’s about the diseases
prevented and the complications averted.
While population health doesn’t make for
great drama, it is vital to reducing the nation’s
health care costs and improving our sagging
health outcomes.
Different -- and most times distinct -- from
health care is public health, the community-

based system of governmental and nongovernmental organizational policies and
services that protect us from disease by
ensuring the water we drink, food we eat,
the air we breathe, and places we live, work,
and play are not hazardous to our health.
Professionals in public health generally
see the community as their patient because
people living in healthy communities are
themselves more likely to be healthy.
As “Obamacare” puts pressure on hospitals
to improve outcomes, population health
has become the new buzzword. Non-profit
hospitals have to justify their charitable tax
exemptions by documenting community
benefit, not just financial solvency. All
hospitals are now judged—and in part
compensated—by outcomes, such as how
often patients return with the same condition
or a related preventable complication.
Through a variety of carrots and sticks,
local health care providers and insurers are
encouraged to address broader community
needs and to take a more patient-centered
approach that emphasizes health outcomes
rather than bottom lines.
Population health bridges the gap
between health care and public health,
encompassing key elements of both.
Health care and public health are viewed
as separate and distinct systems. The
professionals in each have limited access
to, contact with and awareness of each
other. Opportunities for synergy are often
missed. Population health is built on the
premise that health care demand and
quality is affected by the complementary
activities of the public health system.
Conversely, information gathered and
knowledge gained through the delivery of
health care services can inform and direct
more effective public health interventions.
Population health promotes the ideas that:
•O
 ur health care system is more likely to
be efficient and effective when

fully integrated with communitybased programs
•P
 atients heal better and faster when
discharged from the hospital into a
comprehensive home care system
•H
 ospitals are safer when administrators
implement systems designed to eliminate
medical errors and improve outcomes
•H
 ealth care providers perform better
when they have access to a patient’s
complete medical history through a
comprehensive electronic health record
•H
 ealth outcomes are improved and
health care dollars are more wisely spent
when clinicians base their decisions on
evidence derived from objective research
(evidence-based medicine)
•O
 ur life expectancy and health status,
and access to care shouldn’t be
determined by race, ethnicity, gender,
wealth or zip code
•A
 ll of us benefit when our elected
representatives enact health policies
based on sound science.
Health, itself, is difficult to define. Many
people see it as the mere absence of
disease—another day without sickness. But
what about the day before we get sick? Was
there a moment, an opportunity to prevent
illness in the first place? Could an ounce of
prevention save our nation a ton of expensive
cure? The World Health Organization takes
this broad view of health by defining it as
“… a state of complete physical, mental and
social well-being and not merely the absence
of disease or infirmity.”1 Population health is
an effort to achieve this lofty goal. 
Drew Harris, DPM, MPH
Program Director, Health Policy
Jefferson School of Population Health
Drew.Harris@jefferson.edu
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Preterm Birth and the Controversy Over Universal Cervical
Length Screenings
Preterm birth (PTB), defined as birth before
37 weeks gestation, is a major population
health problem. It is the number one cause
of neonatal morbidity and mortality in
developed countries--bearing significant
societal healthcare costs due to short-term
consequences and complications.1 It is a
source of concern for policymakers that PTB
accounts for 12% of all births in the United
States, a higher rate than other developed
nations.2 PTB preventative strategies include
transvaginal ultrasound (TVU) screening and
progesterone administration.3 Though the
exact mechanism of action of progesterone
is not clear, it is thought to provide an antiinflammatory effect and counteract the local
decrease in progesterone levels to decrease
the likelihood of PTB.
In 2012, the Society for MaternalFetal Medicine (SMFM) published
recommendations and the American College
of Obstetricians and Gynecologists (ACOG)
published an opinion statement relevant to
progesterone to reduce PTB.4,5 Though a
number of studies were cited, evidence is
largely supported by two large trials that
found vaginal progesterone reduced PTB
compared to placebo. In 2007, Fonseca et al.
found that a vaginal progesterone suppository
(200mg each night) reduced spontaneous
PTB by 44% (19% vs. 34% in the placebo
group).6 The PREGNANT trial (The Effect of
Vaginal Progesterone Administration in the
Prevention of Preterm Birth in Women With

a Short Cervix), a more recent randomized
multi-center trial, demonstrated the efficacy
and safety of a vaginal progesterone gel
(90mg daily) in reducing PTB risk and
associated neonatal complications. Results
indicated that the vaginal progesterone gel
was associated with a 45% reduction in PTB
before 33 weeks (9% treatment vs. 16%
control) and was associated with a 43%
significant reduction in composite neonatal
morbidity and mortality (8% treatment vs.
14% control).7
The evolving evidence regarding
progesterone has stimulated controversy
as to whether all pregnant women should
receive a TVU screening to detect short
cervix (i.e., universal screening), as opposed
to screening only women determined by
their physician to be at high risk for PTB.
Since high risk is typically defined based on
history of prior PTB, screening only these
women would leave out two major cohorts
of the pregnant population: 1) those who are
pregnant for the first time and have a short
cervix, and 2) those who have a short cervix
despite history of full-term pregnancies.
Proponents of universal screening argue that
it makes sense to support this strategy since
evidence supports the benefit of progesterone
in women found to have short cervix.4 On
the other hand, opponents of universal
screening contend that: 1) there is a lack of
efficacy data specifically on the strategy of
universal TVU screening followed by vaginal

progesterone; 2) the implementation of
proper TVU screening technique is required
in order to ensure accurate results; 3) certain
geographic areas lack sufficient availability
of TVU screening; 4) in certain women,
short cervix can be identified without TVU;
and 5) there is the possibility of differing
results when TVU screening is completed in
practice versus within a clinical trial.4 SMFM
recommendations state that, though there
is currently insufficient evidence to support
universal screening, it is a reasonable practice
for individual physicians to choose.
In summary, while many clinicians currently
support a strategy of universal TVU screening
followed by progesterone in women
detected to have short cervix, this remains an
acceptable but controversial practice. Until
more evidence is available, the issue will
persist as a topic of clinical debate. 
Elizabeth Mearns
Doctor of Pharmacy Student1
Laura T. Pizzi, PharmD, MPH1
Jason K. Baxter, MD, MSCP2
Vincenzo Berghella, MD2
Jefferson School of Pharmacy, Thomas
Jefferson University, Philadelphia, PA

1

Division of Maternal-Fetal Medicine,
Department of Obstetrics and Gynecology,
Jefferson Medical College of Thomas
Jefferson University, Philadelphia, PA

2
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JSPH Graduate Certificate in Population Health
The paradigm has shifted.

The current health system is broken.
We are moving to a new model that stresses population health.
Jefferson’s Graduate Certificate in Population Health is
intended for current and emerging leaders who want to thrive under Health
Reform and implement real world solutions.
• 5 online courses (15 credits)
• 21 months to complete
• $725 per credit

The Certificate will enable you to:
1. Define the population health paradigm and its relationship to the chronic care model.
2. Describe ways in which a population health perspective reorders existing healthcare
priorities and establishes new priorities in areas such as prevention, evidence-based
practice, comparative effectiveness, public health and health policy.
3. Identify and address key determinants of population health outcomes.
4. Identify and characterize key stakeholders, including governmental and private
sector institutions, and analyze how their complex relationships influence
population health outcomes.
5. Analyze the impact of health care and health services on population health outcomes
and identify strategies for improving healthcare quality and safety.
6. Analyze the relationship of population health outcomes to health economics
and to value in health care.

Curriculum
•
•
•
•
•

Population Health and Its Management
U.S. Healthcare Organization and Delivery
Introduction to Healthcare Quality and Safety
Chronic Illness Prevention and Chronic Care Management
Introduction to Health Economics and Outcomes Research

Admissions Considerations
• Bachelor’s degree with GPA of 3.0
• GRE or other graduate entrance exam or graduate degree or 9 graduate credits

For more information: Samia.White@jefferson.edu or 215-503-0174
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New Jersey Vaccine Mandates: The Confluence of Regulations,
Rights, and Religion
Vaccines rank among the top ten public
health achievements of the past century,
along with food safety, control of infectious
diseases, healthier mothers and babies,
automobile safety, fluoridation of drinking
water, family planning and others. The
sad irony is that our success in eradicating
scourges like smallpox, polio and diphtheria
is threatened by unfounded fears regarding
vaccine complications. Across the nation,
the public health community is confronting
a backlash against state vaccination
requirements spearheaded by small but vocal
groups of anti-vaccine activists concerned
about vaccine safety and issues of personal
choice.1 In New Jersey’s case, legislation to
tighten religious exemption regulations is the
current focal point for their lobbying efforts.
Mandatory childhood vaccination was
a key element in our success in the
war against deadly infectious diseases.
Voluntary efforts do not ensure enough
children are vaccinated to prevent efficient
person-to-person transmission of vaccinepreventable disease—often called “herd
immunity.” Without susceptible people to
infect, infectious agents hit a dead end and
the disease outbreak ultimately dies out.
Children are at higher risk for these diseases
and are more likely to spread it to vulnerable
populations such as infants, immunocompromised people and the elderly.
Every state in the nation has a law requiring
school children to be vaccinated against
serious illness such as measles, mumps,
rubella, polio and others. All states exempt
individuals with medical conditions that
put them at risk for complications from
the vaccine, and all but two states provide
for religious exemptions. Nineteen states
allow parents to opt their children out of
the vaccines over philosophic or moral
concerns.2 States that only require a simple
statement of objection, rather than a more
rigorous exemption process, are seeing a
significant increase in outbreaks of vaccinepreventable disease.3, 4, 5
This controversy is not new. In 1902,
Henning Jacobson refused an order of
6
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the Cambridge, Massachusetts Board of
Health requiring him to take a smallpox
vaccination, claiming that the requirement
violated his personal liberty. He was fined
$5 as a result. He appealed his case to the
US Supreme Court, which sided with the
Board saying that the “…community has
the right to protect itself against an epidemic
of disease.”6 Jacobson v. Massachusetts
became the seminal case codifying the
principle that community wellbeing can
trump individual liberty and that public
health agencies have the authority to impose
these requirements.
In its decision, the Supreme Court allowed for
medical exemptions, but denied exemptions
for religious or philosophic beliefs. The
courts have generally held in other cases
that the religious freedoms guaranteed by
the First Amendment can be curtailed, when
necessary, to protect public health.7
States are not constitutionally required to
grant religious exemptions, but when they
do the procedure by which exemptions are
granted must comport with the Constitution.
For example, the government cannot require
proof of membership or regular attendance
at services of an “established” religion
before granting an exemption. To do so
would run afoul of the First Amendment
prohibition against the government
establishing a religion. However, it can
require proof of the sincerity of one’s
religious belief; applying the principles used
to assess the veracity of the conscientious
objectors to required military service. No
conversions are allowed on the way to the
draft board.
It is this issue of the nature of the religious
objection against the vaccination mandate
that is in question in New Jersey. State law
mandates that parents provide proof of a
child’s appropriate immunization against
a variety of diseases prior to attendance
at daycare, school or college.8 The law
leaves enforcement to local public health
and school officials. Standards for granting
exemptions have varied across jurisdictions
and some officials may have been requiring

proof of church membership rather than
examining the sincerity of the beliefs.8
In response to a request for guidance from
local officials, the New Jersey Department of
Health and Office of Attorney General issued
interim policies and ultimately regulations
that said no inquiry into the nature of a
family’s religious belief could be made
before granting an exemption.8 All that could
be required was a written statement from
the parents that included the word “religion”
or “religious.” Officials could not inquire
how long the belief was held; whether the
child received some but not all vaccines, or
if other family members were vaccinated;
if their primary concern was the safety of
the vaccine; or if they would vaccinate
against the disease if it presented itself in the
community. In essence, anyone could claim
a religious exemption for reasons that had
nothing to do with religion.
A preliminary analysis of school
immunization reports revealed that the
number of students with active religious
exemptions statewide went from 1,625
in 2007, prior to the change in standards,
to 6,204 in 2011 or 1.2% of the sampled
population (Harris: unpublished data).
While it can’t be proven that the
regulatory change allowed for more
religious exemptions, anecdotally there
was evidence (via online forums) that
parents whose objections to vaccinations
were more philosophic or safety-related
were exchanging tips on how to obtain an
exemption based on religious objection.
These new regulations effectively
converted New Jersey’s current law limiting
vaccine mandate exemptions to medical
or religious grounds into a law allowing
liberal philosophic exemptions. The data
supported the concern that the number of
under-immunized children was quickly
approaching a level similar to states with lax
philosophical exemption standards, putting
the state at risk of major outbreaks.
The New Jersey state legislature is
considering a bill (S 1759)9 that will make

explicit the process for granting religious
exemptions and follow judicial precedent
allowing for appropriate verification
of religious exemption claims. Recent
outbreaks of pertussis10,11 and mumps
are just a foreshadowing of what might
be coming if the state continues to allow

parents unqualified access to the religious
exemption process.

shots that protected not only themselves but
everyone else. 

Immunity against vaccine-preventable
disease is a community resource,
bequeathed to us by generations past and
current who rolled up their sleeves for

Drew Harris, DPM, MPH
Program Director, Health Policy
Jefferson School of Population Health
Drew.Harris@jefferson.edu
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Online Information Sessions
Public Health

Wednesday, May 8, 2013 • 12 noon – 1 pm ET

Applied Health Economics and Outcomes Research
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Healthcare Quality and Safety

Healthcare Quality and Safety Management
Thursday, May 16, 2013 • 12 noon – 1 pm ET

Onsite Information Session
Public Health

Wednesday May 15, 2013 • 5:30 – 7:00 pm
901 Walnut Street, 10th Floor
Philadelphia, PA 19107
For more information call (215) 503-6125 or visit:
http://www.jefferson.edu/population_health/campus_events.html
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The Bernard Wolfman Civil Discourse Forum
Beth Shalom Congregation
March 28, 2013

It was Bernard Wolfman’s love of words
that inspired the creation of the Bernard
Wolfman Civil Discourse project, and
the inaugural Civil Discourse on the
topic of the role of government in health
reform. On March 28, 2013, the fourth
night of the Jewish Passover, David
Nash, MD, MBA and Stuart Butler, PhD,
drew a crowd of over five hundred to
Beth Shalom Congregation in Elkins
Park, Pennsylvania, where they engaged
in a public conversation moderated by
Chris Satullo, WHYY vice president for
news and civic dialogue, and co-founder
and co-director of the Penn Project for
Civic Engagement at the University of
Pennsylvania. Distinguishing between civil
discourse and talk-show debate, Satullo
defined civil discourse as an ‘exploration’
of ‘shared identities’ and leveraging
‘intellectual and ideological diversity to
model a means to generate effective public
policy.’ The two candidates agreed not
to argue or debate, despite their differing
views on government’s role in health care.
Stuart Butler, PhD is currently serving
as Director of the Center for Policy
Innovation at The Heritage Foundation,
a conservative think tank located in
Washington, DC. An expert in the areas
of Medicare, entitlements, and health
care reform, Butler identified three main
influences on his political views: the ethics
and values of Judaism, the principles of
market economics, and the principles of
federalism. He went on to ask although
the general consensus is that Americans
ought to have ‘equitable, affordable care,’
what level and how much health care
should Americans expect? He expressed
his concern over what he views as a
‘spend then bill’ system, which lacks a
concrete budget. A staggering hypothetical
statistic supported Butler’s concerns: if
the United States’ health care system were
its own economy, it would be the sixth
largest economy worldwide, surpassing
both France and Britain. Butler also
expressed his specific concern over the
recently passed Affordable Care Act; “If
8
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Above: David Nash, MD, MBA (left) and Stuart Butler, PhD. (right).
government cannot organize a system of
records, can government come in to the
exam room?”
David Nash, MD, MBA, Dean of Jefferson
School of Population Health and a
practicing internist, emphasized right away
the need for eliminating waste in our health
care system. Nash identified six areas of
waste: overtreatment, failure to coordinate
care and the lack of follow up, failure in
execution, administrative failure, pricing
failure, and fraud/abuse, the elimination
of which would allow the US to fix its
broken system. Nash also supplied his own
hypothetical statistic; with medical errors
currently the fourth leading cause of death
in this country, it is akin to a 747 crashing
every day, killing all its passengers. He went
on to express his continued outrage that
this persists, “What other industry would
tolerate this?” Nash agreed with Butler’s
observation that healthcare spending is out
of control in this country, at 20% of the
gross domestic product, but disagreed with
Butler, remarking that ‘only Uncle Sam has
the power to rein in spending, change the
payment process to reduce waste.’

Above: David Nash (top); Stuart Butler
(left) and Chris Satullo (right).
While they differed in their perspectives
of the government’s role in health care, the

two experts did converge on a number of
details. When asked about the idea that
most healthcare spending comes about
in the last two years of life, both Butler
and Nash agreed that Americans need to
start having more conversations with their
loved ones and their providers about end
of life. Dr. Nash went a step further to say
that one way to ensure this conversation
takes place would be to create a Medicare
fee for the end of life conversation. Ever
the educator, he also indicated that this
is a huge opportunity for an educational
piece. Both speakers also agreed on the
importance of care coordination and
accountability on the part of both patient
and provider.
When asked by Satullo about the
implementation of a single payer system
in the United States, both experts said
that they didn’t believe it would work,
and each offered a humorous explanation

of why. Butler gave a nod to his British
roots when he said “British people see a
line, they get in it, and then ask what it’s
for.” Americans will not wait for health
care. He also expressed his concern that
if implemented, a single payer system
might eliminate the worry of being
bankrupted by medical bills at the expense
of not receiving medical care at all. He
ended by saying that healthcare requires
flexibility, and the federal government
cannot be flexible. Nash weighed in on
implementing a single payer system by
stating, “I like my Lipitor on the way to
McDonalds. I want you to buy the Lipitor,
and I’ll buy the Big Mac.” Nash offered
advice to fix the broken system in the form
of a seven point plan: a greater level of
patient engagement, including an open
medical record; simply asking caregivers
if they have washed their hands; the
Choosing Wisely campaign; encouraging
end-of-life conversations; behavioral

modifications such as exercise, wearing
seatbelts, and stopping smoking; finding
a primary care doctor and visiting that
doctor: and finally, practicing charity.
Though the evening ended without
a “debate winner” guests were left
with evidentiary proof that a civil
conversation between adversaries can
lead to convergences and opportunities
to work toward common goals. The
Project’s namesake, who treasured his
Oxford Dictionary and his Merck Manual
of Medical Information, believed in
maintaining respect in a disagreement, a
principle upheld by both speakers. 
Kate Cecil, MS
Project Manager
Jefferson School of Population Health
Kate.Cecil@jefferson.edu

Joseph S. Gonnella, MD Scholarship Awarded to Evan Bilheimer
The Jefferson School of Population Health
(JSPH) has award the Joseph S. Gonnella,
MD Scholarship to Evan Bilheimer, a
Jefferson Medical College (JMC) student
who recently completed his third year of
medical school and is entering the MPH
program at JSPH. He received high
honors in Neurology and Pediatrics in Fall
2013 and he participates in the College
within a College, Population Health
voluntary scholarly concentration.
The Joseph S. Gonnella Scholarship
is named in honor of Dr. Gonnella,
Distinguished Professor of Medicine,
former Dean of Jefferson Medical College,
and founder and director of JMC’s Center
for Research in Medical Education and
Healthcare. This merit-based award is
intended specifically for highly qualified
students of JMC who wish to pursue an
MPH in addition to their medical degree.
Bilheimer graduated from the University
of Rochester in 2009, Magna Cum Laude,
with degrees in History and Chemistry.
During his time in undergraduate school,
Bilheimer volunteered for two medical

service trips abroad for Shoulder to
Shoulder, Inc. After graduation, he
worked for AmeriCorps as an HIV
Counselor and Teen Substance Abuse
Youth Group Leader at the Massachusetts
League of Community Health Centers,
Neponset Health Center in Dorchester,
Massachusetts.

the changing health care environment and
practice transformation. He is committed to
providing equitable and quality healthcare
to patients and populations.

Since entering medical school, he
participated in the Bridging the
Gaps Community Health Internship
program providing health education
and programming at To Our Children’s
Future with Health, a community-based
non-profit agency. Bilheimer has also
volunteered with JeffHOPE and the
Refugee Health Partner’s Houston Clinic.
Bilheimer intends to pursue a career in
Family Medicine by providing preventive
community health services and becoming
involved in the administration and delivery
of healthcare at the systems level. He
believes the MPH program will equip him
with skills for evaluating and managing
the various social determinants of health,
while becoming actively involved with
SPRING 2013 | 9

Global Health: Innovation/ Implementation / Impact
A report on the Fourth Annual Conference of the Consortium of Universities for Global
Health (CUGH)
Nine representatives from Thomas Jefferson
University, including two from the Jefferson
School of Population Health (JSPH),
attended the fourth annual conference of
the Consortium of Universities for Global
Health in Washington, DC (March 14-16,
2013). The theme was Global Health:
Innovation/Implementation/Impact. The
program featured world-renowned keynote
speakers and plenary panels addressing
the complexity of today’s global health
challenges and highlighting a diverse group
of experts from a broad range of sectors.
It was clear that solving global health
problems requires a collaborative approach
that harnesses the skills and energies of
multiple disciplines, promotes cooperation
across multiple sectors and embraces
innovation. Over 1,390 people attended
the conference, representing more than 56
countries. More than 230 speakers presented
in the concurrent and special sessions and
308 posters were on view; two of the posters
were from the JSPH. A third of the posters
focused on education and capacity building
in global health.
The conference began and ended with
inspiring presentations from the very
dynamic Agnes Binagwaho, MD, M(Ped),
Minister of Health, Rwanda. Plenaries
addressed the issues of: Global leaders in
global health; US Government Agencies
for Global Health; Innovative financing
mechanisms for global health; Innovative
technologies and approaches for global
health: transforming the present and future;
Global health justice: Empowering women,
catalyzing change; and Climate change
and global health: using science to protect
populations. The four prominent directors
of US Government Agencies for Global

Health were particularly impressive: Francis
Collins, MD, PhD, Director National
Institutes of Health (NIH); Thomas Frieden,
MD, MPH, Director, Centers for Disease
Control and Prevention (CDC); Eric Goosby,
MD, US Global AIDS Coordinator, Office
of Global Health Diplomacy; and Jonathan
Woodson, MD, Assistant Secretary of
Defense (Health Affairs) and Director
of TRICARE Management Activity, US
Department of Defense.
Special sessions on the Role of NIH in
Global Health Research, Crisis in the
Sahel and the Global Burden of Disease
(GBD): 2010 Report1 were both timely
and informative. The session on the Global
Burden of Disease by Christopher Murray,
MD, DPhil, Director, Institute for Health
Metrics and Evaluation used innovative
technology to present the GBD report
which facilitates comparisons across a
multitude of mortality, morbidity, and
quality of life indicators on 291 diseases
and injuries, 67 risk factors, and over 1000
sequellae from 186 countries2 and was
truly amazing.
The concurrent sessions covered a very
broad range of topics and disciplines.
Topics included: mHealth, oral health,
OneHealth, community health, scaling
for impact, climate change, human rights,
primary health care, women’s health, global
local health, social media. Key themes that
ran throughout include: the importance of
collaborating with China and Latin America;
developing a sustainable health work force;
partnering with faith-based organizations
and the private sector; and creating crossdiscipline approaches to address malaria and
neglected tropical diseases.

Overall, some of the key themes and take
away messages of this conference were
focused on:
• I nnovation (i.e. mHealth, eHealth,
telemedicine, technology) as the means
of communication, analysis, and
treatment for the future.
•G
 lobal health programs are also local or
“glocal” problems.
•R
 esearch and sharing research findings
with subjects of research is key to policy.
development and targeted programs.
Resolving global health issues requires a
collaborative cross-cutting approach that
encompasses multiple disciplines, promotes
cooperation, and embraces innovation.
The Jefferson team has been meeting in an
attempt to capture the best from the CUGH
conference to apply it to the improvement of
the TJU global health education programs. 
Lucille B. Pilling, EdD, MPH, BSN, RN
Lecturer, Global Health, Jefferson School
of Population Health
Adjunct, Assistant Professor of Nursing,
University of Pennsylvania School of Nursing
Lucille.Pilling@jefferson.edu
Rob Simmons, DrPH, MPH,
MCHES, CPH
Associate Professor
Program Director, Public Health, Jefferson
School of Population Health
Rob.Simmons@jefferson.edu
For more information on this conference
visit: http://2013globalhealth.org/

REFERENCES
1. The global burden of disease study 2010. The Lancet. Published December 13, 2013. http://www.thelancet.com/themed/global-burden-of-disease. Accessed April 5, 2013.
2. Institute for Health Metrics and Evaluation. GB Compare Tutorial. 2013. http://www.healthmetricsandevaluation.org/gbd/multimedia/video/gbd-compare-tutorial.
Accessed April 24, 2013.
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National Public Health Week
Meeting Again at the Crossroads: Social Work and Public Health
April 4, 2013

Although social work and public health share historical roots, their paths have diverged until recently. Today’s complex health issues
require the expertise of both professions. This year’s Public Health Week symposium and luncheon explored the intersections among
public health, social services, health care and policy. Moderated by Dr. Bailey, Dean and Professor of the Graduate School of Social
Work and Social Research at Bryn Mawr College, the panelists discussed the importance of a multidisciplinary perspective on health;
implications of social work and public health principles for health and well-being; and the need for cross-disciplinary collaborations.
The Jefferson School of Population Health and the Bryn Mawr College of Graduate School of Social Work and Social Research
(GSSWSR) have partnered to offer dual degrees in social work (Master of Social Service – MSS) and public health (Master of Public
Health – MPH). For more information about this exciting dual degree program, visit:
http://www.jefferson.edu/population_health/academic_programs/dual_degrees/mss-mph-dual-degree-program.html

Panelists from left to right: Christina Miller, MSS; Jennifer Campbell, PhD; Cindy Sousa, PhD, MSW, MPH; Joanne Fisher, MSS, and
Darlyne Bailey, PhD, LISW
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Global Health in the World’s Youngest Nation
The Department of Emergency Medicine
at the Thomas Jefferson University has
offered a two-year Fellowship in Global
Health since 2011. Fellows work part-time
as attending physicians in the Emergency
Department, and study towards a Master
of Public Health degree at the Jefferson
School of Population Health, while
spending three months per year doing
fieldwork. As our department’s first Global
Health Fellow, I volunteered (May August 2012) with a non-governmental
organization called International Medical
Corps (IMC) in the East-African nation of
South Sudan.

the LuoNuer and the Murle. Both tribes
live in tukuls (mud and straw huts) and
survive off of a combination of subsistence
agriculture, fishing, and raising cattle and
goats. A custom the tribes have in common
is that they use cattle as dowry; a man must
give a woman’s father roughly 20 cows to
secure her hand in marriage. This need for
cattle has led the two tribes to carry out
raids on each other’s herds. Cattle raiding,
combined with a history of conflict between
the tribes, has resulted in deadly and
ongoing violence that has only worsened
with the introduction of automatic weapons
during the long civil war.

South Sudan seceded from Sudan in July
2011 to become the world’s youngest
nation. The country was wracked by
almost 60 years of civil war, leaving
the South one of the most undeveloped
countries in the world and with some of the
poorest economic and health indicators in
all of Africa. It has less than 200 miles of
paved roads, only 16% of the population
has access to healthcare of any kind, and
for every 100,000 births over 2,000 women
die from the complications of delivery.

IMC operates the Akobo County Hospital –
the only hospital for hundreds of kilometers
in every direction. IMC employs one doctor
at the hospital; the remainder of the medical
staff there is composed of community health
workers, clinical officers, and assistant
nurses. Staff have had anywhere from three
months to two years of medical training.
While they are hardworking and dedicated
to their community, I found that many
of them had extremely limited reading,
writing, and math skills, which sometimes
led to errors such as incorrect medication
dosages or administration.

IMC has had aid and development
programs in many parts of South Sudan
prior to its secession from the North. One
of their most long-standing programs is
in Akobo County on the eastern border
of country. Akobo has no paved roads
and heavy rains turn large swaths of the
county into impassable swamps for almost
nine months out of the year. The standing
water is a perfect breeding ground for
mosquitoes that carry malaria and the thick
mud makes walking just a few hundred
meters an energy-sapping slog.
The people of Akobo mostly come from
one of two tribes that have a long-standing
history of deadly conflict between them:
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I worked on an IMC project funded by the
UN’s Common Humanitarian Fund and
the European Community Humanitarian
Office to improve care for traumatically
injured patients in Akobo County. People
in Akobo may suffer trauma due to falls
or farming accidents, but the majority of
serious trauma is due to gunshot wounds
or stabbings that occur during inter-tribal
conflicts. Working with IMC employees
and volunteers, I developed a curriculum
to teach hospital medical staff and lay
community members skills and concepts
that are important to treating trauma
victims. Some of the topics we covered

included mass casualty triage, stabilization
of bleeding or burned patients, and
splinting of broken bones.
Curriculum development proved to be
especially challenging in this environment.
For one, the majority of the people we
were targeting for training did not speak
English and were not literate. We also
had no reliable source of electricity, so
the lectures and training sessions had to
be given using only a dry-erase board
and some printed diagrams. Additionally,
medical resources at the hospital were very
limited so the material had to be closely
tailored to what was on-hand; x-rays were
not available so we did not discuss x-rays.
To overcome some of these challenges we
made use of local interpreters and used
simulations to teach clinical principles.
During this global health project I learned
firsthand about some of the challenges
of developing and implementing a health
education program. These experiences will
help guide me during future public health
projects. The project in Akobo is ongoing
and a new set of IMC employees and
volunteers is currently in Akobo County.
There is some hope for South Sudan overall
as the conflict over oil production with
Sudan is being gradually resolved. 
Masashi Rotte, MD
Assistant Professor and Fellow in
Global Health
Department of Emergency Medicine
Thomas Jefferson University
MPH candidate, Jefferson School of
Population Health
For more information on the Global Health
Fellowship contact Dr. Harsh Sule at
Harsh.Sule@jefferson.edu.
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The Quality and Safety Leadership Series
JSPH has recently launched a live series of educational programs focused on quality and safety.
As healthcare expenditures continue to
rise, stakeholders across the healthcare
system are searching for ways to improve
the quality of care and optimize the use of
resources. Achieving these goals requires
engaging and educating each participant
– patient, payer, and provider – so they
can better understand the issues and work
together toward meaningful solutions.
The Patient Protection and Affordable
Care Act has led to the introduction of
several new initiatives aimed at increasing
accountability for outcomes and delivering
a higher return on healthcare expenditures.
To help all stakeholders understand
and adapt to this transition, JSPH has
developed a live educational series focused
on quality and safety leadership. The
faculty for this program is drawn from

among some of the top experts in the field
from across the country.
The Quality and Leadership Series (QSLS)
is a live series of customized educational
programs designed to meet the unique
needs of healthcare professionals, whether
they have clinical or administrative
responsibilities. Through the generous
support of Sanofi US, JSPH developed
this series to connect some of the
nation’s foremost experts to healthcare
professionals across the country.
Programs are geared toward institutions
and professional associations seeking to
learn how to improve the quality and safety
of healthcare delivery. Content is adapted
for each program to meet the unique needs
of each audience and organization that

requests a program. There is no cost to
the requesting organization; JSPH simply
requests that all attendees complete a postprogram evaluation.
JSPH maintains a catalog of faculty and
topics, available at http://www.jefferson.edu/
qsls. QSLS program staff work to identify
appropriate faculty based on the information
submitted, and work closely to facilitate
program planning between the speakers and
the requesting organization. 
For more information or to request a QSLS
program, visit http://www.jefferson.edu/
qsls for a request form that can be sent via
e-mail to QSLS staff at qsls@jefferson.edu.
You may also contact us by phone at
(877) 662-7757.

Practice Improvement Strategies:
Online CME Opportunity
The Jefferson School of Population Health is establishing exciting new partnerships to enhance professional development and CME
opportunities that are directly relevant to clinical practice in this changing healthcare landscape. A recent collaboration, The Johns
Hopkins University Practice Improvement Strategies in Cardiometabolic Disease Therapies, presents a complimentary PICME activity that provides primary care physicians, endocrinologists, cardiologists, NPs and PAs with the tools to measure quality
of care and to identify opportunities to improve the outcomes for their patients with cardiometabolic disease.
All practicing clinicians can earn 20 CME/CE credits without the need to attend a live or online program. After collecting some
basic data on their patients, participants will be provided with benchmarking reports that satisfy American Board of Internal Medicine
(ABIM) MOC Part IV requirements. Participants will also receive detailed clinical reports analyzing care delivered to patients with
cardiometabolic disease against individual peers (anonymously) and national trends. The program will also provide exclusive access to
a secure and moderated “mentor program,” an online Q&A forum with nationally-recognized experts in the field.
Clinicians are invited to share the benefits of the educational grant funding that supports this program. Each participating practice
is eligible to receive $500 to support the collection of data on 25 patients with diabetes, hypertension, dyslipidemia and/or obesity.
Funds are limited and will be awarded on a “first come, first served” basis. Interested practices are encouraged to complete a brief
registration online at http://jhucardio.imedicaldecisions.com, or to contact us by email at PIsupport@imedicaldecisions.com, or to
call (610) 891-1640.
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to
provide continuing medical education for physicians.
The Johns Hopkins University School of Medicine designates this PI CME activity for a maximum of 20.0 AMA PRA Category 1
Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
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Population Health Forums
The Choosing Wisely® Campaign: Is This a Game Changer?
Daniel B. Wolfson, MHSA

Executive Vice President and Chief Operating Officer
American Board of Internal Medicine Foundation
January 9, 2013

Have you ever received unnecessary care?
This is how Mr. Wolfson, Executive Vice
President and Chief Operating Officer of
the ABIM (American Board of Internal
Medicine) Foundation initiated the
discussion on “overuse” in healthcare.
The ABIM Foundation is a not-for-profit
organization focused on advancing medical
professionalism and physician leadership to
improve the health care.
Wolfson described overuse as unnecessary
procedures where the benefits don’t exceed
the risks. The problem of overuse and
overtreatment is staggering in the US.
Wolfson explained that over $200 billion
per year is wasted on overtreatment.
The Choosing Wisely® campaign of the
ABIM Foundation is an initiative that
is aimed addressing this problem by
helping physicians and patients engage in
conversations about the overuse of tests and
procedures, and support physician efforts

to help patients make smart and effective
care choices. The major components
of the campaign include: simplicity,
unexpectedness, concreteness, credibility,
emotions, and stories. Wolfson shared his
own personal stories to illustrate the classic
examples of overtreatment.
An important component of the Choosing
Wisely® Campaign is the document, Five
Things Physicians and Patients Should
Question, a series of lists representing 25
specialty societies in the US. By recognizing
the significance of patient and provider
conversations, the tool is aimed at improving
care and eliminating overtreatment. The
comprehensive lists include scientific,
evidence-based recommendations to help
make decisions about the most appropriate
care. Consumer Reports, a partner of
Choosing Wisely,® has produced over
35 patient-friendly materials based on
medical society recommendations that will

disseminate information about appropriate
use of medical tests and procedures.
Wolfson explained that the success of the
campaign is based on intrinsic motivation
and a shift in cultural attitude. For example,
the emphasis should be on “why”: “Why did
you need that procedure or test?” rather than
“Why didn’t you do that procedure or test?”
The campaign will continue to grow
and flourish as it galvanizes multiple
stakeholders (i.e. office practices, residency
and medical training programs, health
systems) to advance the campaign. 
To learn more about the Choosing
Wisely® Campaign visit:
http://www.choosingwisely.org/
To read Mr. Wolfson’s Medical
Professionalism Blog visit: http://blog.
abimfoundation.org/about_our_authors/

New Therapeutic Options for Stroke Prevention in Atrial Fibrillation
Joseph D. Jackson, PhD

Program Director, Applied Health Economics and Outcomes Research
Jefferson School of Population Health
February 13, 2013

Anti-coagulation therapy for stroke
prevention in Atrial Fibrillation (AF) has
been dominated by the drug warfarin for
more than 50 years, yet three recently
approved drugs are viable therapeutic
alternatives to warfarin. However, according
to Dr. Jackson, Program Director for Applied
Health Economics and Outcomes Research
at JSPH, they are not without challenges to
optimize care for AF patients. He helped
provide a clear and insightful overview of
this topic at a recent Forum. Dr. Jackson
has over 30 years of experience in the
pharmaceutical industry, with much of this
time devoted to clinical research and the

management and practice of Outcomes
Research, including the transition of
clinical evidence into user-friendly costeffectiveness models.
The framework for Dr. Jackson’s presentation
was based on outcomes research, which
he described as the “study that studies the
studies.” The purpose of outcomes research,
according to the Agency for Healthcare
Research and Quality (AHRQ), is to examine
three questions: 1) Do patients benefit? 2)
What treatments work best? And, 3) Are
health-care resources well spent?

Jackson first cited the incidence of AF
by explaining that approximately 15% of
all strokes occur in people with AF; the
risk of stroke in patients with untreated
AF averages 5% per year and increases
with advancing age. Jackson emphasized
the chronic and devastating nature of AF
and the importance of understanding the
efficacy and the effectiveness in the real
world of therapeutic options.
For many years, warfarin has been the
only oral anti-coagulant available for
chronic care. Though hugely successful in
terms of stroke prevention, its use presents

Continued on page 16
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numerous challenges in everyday practice,
particularly for chronically ill, elderly
patients. For example, warfarin is known to
have many interactions with other drugs and
foods, and requires constant monitoring.
There is a narrow therapeutic range, and
the blood test monitoring of the INR
(International Normalized Ratio), can be a
significant barrier for certain populations as
well as caregivers. Most significant is that
warfarin is a leading cause of adverse drug
events and associated visits to emergency
rooms, Jackson explained.
A new group of anti-coagulants, called
“Novel Oral Anticoagulants” or NOAC,
including dabigatran, rivaroxiban, and
apixaban, open the door for promising

alternatives to warfarin, with fewer
complexities in the treatment regimens.
Dr. Jackson offered an overview of the
major clinical studies, and even indirectly
compared some of the findings, after
warning the audience about the dangers of
indirect comparisons.

safety and effectiveness are confirmed, their
promise of a superior alternative to warfarin
remains to be seen. He closed by affirming
that most effective therapies prove costeffective, and for the NOACs real-world
scenarios will be crucial to assess their
ultimate value.

Relating this back to outcomes research,
Jackson tackled the questions, “what
treatment works best?” and “are healthcare
resources well spent?” NOACs, he
explained, are unique compared to warfarin
in that they don’t need INR monitoring,
but as anti-coagulants they still need
careful oversight. In many key outcomes,
NOACs were actually superior or better
than warfarin; however, until real-world

Throughout his presentation, Dr. Jackson
acknowledged the work and expertise of
Geno J. Merli, MD, Co-Director of the
Vascular Center at Jefferson, and a national
expert on anticoagulant therapy. 
For more information visit:
http://www.theheart.org/columns/clot-blog.do

Moving The Needle: Challenges and Opportunities in Communicating Patient-Centered
Outcomes Research
Bill Silberg

Director of Communications
Patient-Centered Outcomes Research Institute (PCORI)
March 20, 2013

The Patient-Centered Outcomes Research
Institute (PCORI) is an independent
non-profit research organization charged
with the task of helping the public make
informed decisions and improving health
care delivery and outcomes by producing
high-quality evidence-based research.
PCORI was authorized by Congress as
part of the 2010 Patient Protection and
Affordable Care Act (ACA). Bill Silberg,
Director of Communications at PCORI,
shared an insightful overview of PCORI’s
mission and initiatives at a recent Forum.
Silberg first described PCORI’s
commitment to seeking input from a
diverse range of stakeholders, including
patients. Patients and caregivers are
viewed as a meaningful part of the
research team and Silberg discussed the
importance of bringing a broad range of
voices to the work of PCORI. Silberg
used the term “research done differently”
to characterize the way in which PCORI
strives to shape its purpose.
Silberg went on to discuss the details of
the National Priorities for Research and
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the Research Agenda which include:
assessment of prevention, diagnosis,
and treatment options; improving
health care systems; communication
and dissemination research; addressing
disparities; and accelerating PCOR and
methodological research. These priorities
are intentionally designed to be broad and
process oriented.
The PCORI Board of Governors has
approved a number of pilot projects
throughout the United States. The projects
are predominantly population specific,
and focus on ways of engaging patients in
research and the dissemination process.
Examples include a project on how
physicians and patients talk to one another
more openly, to a pilot project on the
use of mobile apps for patient caregiver
attitudes, behavior, and knowledge, and a
project on reducing disparities in a rural
population with multiple cardiovascular
disease risk factors.
Throughout his presentation, Silberg
acknowledged that comparative
effectiveness research (CER) and PCOR

are not the easiest topics to communicate
to the public, but he believes that PCORI
can build visibility, focus on results and
lessons learned, and discover powerful
patient stories that can be shared.
As Silberg pointed out, “moving the needle”
requires significant change in researcher
culture, norms, attitudes, skill, and policies.
There are multiple influences and constraints
acting simultaneously on stakeholders and
researchers. He stressed the importance of
identifying key stakeholders and the need
to plan collaborative activities as a way to
effect change. Silberg explained that change
will occur slowly and requires a long-term,
multi-phase/multi-component plan. The
focus should be on facilitating awareness,
promoting education and training,
facilitating feasibility, establishment of
comprehensive range of incentives and
rewards. Simply put, “research done
differently.” 
To listen to Forum podcasts and
access presentations visit:
http://jdc.jefferson.edu/hpforum/

Jefferson School of Population Health invites you to join the Grandon Society, a
membership organization comprised of individuals and organizations focused on advancing
population health. Named for our longtime benefactor and champion, Raymond
C. Grandon, MD, and his wife, Doris, the Grandon Society is designed for leaders
throughout the healthcare sector who are dedicated to transforming the US health care
system through collaboration, education and innovation.
Benefits of membership include exclusive member-only programs and events, a member
e-newsletter, and early notice and special registration rates for JSPH conferences and events.
Memberships are available for individuals and for organizations, with special rates for
academic, non-profit and government institutions.
For more information or to join the Grandon Society, visit:
http://www.jefferson.edu/population_health/GrandonSociety.html.

Robert W. Dubois, MD, PhD, Chief Scientific Officer at the National Pharmaceutical Council, responds to questions at recent
Grandon Society Member-Only workshop.
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JSPH Publications
Aubry W, Lieberthal RD, Willis A, Bagley
G, Willis SM, Layton A. Budget impact
model: epigenetic assay can help avoid
unnecessary repeated prostate biopsies and
reduce healthcare spending. Amer Hlth &
Drug Benefits. 2013;6(1):15-24. http://www.
ahdbonline.com/feature/budget-impactmodel-epigenetic-assay-can-help-avoidunnecessary-repeated-prostate-biopsies-a

imagine: A report on the UHC Annual
Conference 2012. AJMQ. 2013.28 (IS)
Clancy Z, Keith SW, Rabinowitz C,
Ceccarelli M, Gagne JJ, Maio V. Statins
and colorectal cancer risk: a longitudinal
study. Cancer Causes Control. January 20,
2013.[Epub ahead of print].
http://link.springer.com.proxy1.lib.tju.edu/
article/10.1007%2Fs10552-013-0160-x

Berman B, Pracilio VP, Crawford
A, Behm WR, Jacoby R, Nash DB,
Goldfarb NI. Implementing the physician
quality reporting system in academic
multispecialty group practice. Lessons
learned and policy implications. AJMQ.
Published online before print March 12,
2013. doi:10.1177/1062860613476733.
http://ajm.sagepub.com/content/
early/2013/03/12/1062860613476733.
full.pdf+html

Lieberthal RD, Dudash K, Axelrod R,
Goldfarb NI. An economic model to value
companion diagnostics in non-small-cell
lung cancer. Personalized Medicine.
2013; 10(2), 139-147. http://www.
futuremedicine.com/doi/abs/10.2217/
pme.13.7?journalCode=pme

Berman B. Patient safety in ambulatory
care: a REAL challenge. Abstract in: Re:

Nash DB, Baxter L. Implementing the
patient-centered medical home model
for chronic disease care in small medical
practices: practice group characteristics
and physician understanding. AJMQ.
2013;28(2):113-119.

Nash DB. Technology trends in
healthcare. Amer Hlth & Drug Benefits.
2013; 6(1):12-13.
Nash DB. Zero tolerance for medical
error? Think again! MedPage Today.
February 27, 2013.
Nash DB. Is the doctor on to something?
MedPage Today. March 27, 2013.
Plumb E, Roe K, Plumb J, Sepe P, Soin
K, Ramirez A, Baganizi E, Simmons R,
Khubchandani J. The use of international
service learning initiatives for global health
education: case studies from Rwanda and
Mexico. Health Promotion Practice. 2013;
Published online before print March 14,
2013, doi: 10.1177/1524839913476516.
http://hpp.sagepub.com/content/early/
2013/03/01/1524839913476516.full

JSPH Presentations
Baghdassarin A, Donaldson R,
DePiero A, Chernett N, Sule H.
Knowledge and attitudes assessment of
out-of hospital emergency physicians in
Yerevan, Armenia. Poster presented at:
Consortium of Universities for Global
Health (CUGH) conference, March 1416, 2013,, Washington, DC.

Populations, Achieving Equity in an Era
of Innovation and Health System Reform,
March 13, 2013, Oakland, CA.

Berman B. Screening for elder
maltreatment: an environmental scan of
the evidence. Webinar presented at: CMS
Elder Maltreatment and Care Symposium,
March 8, 2013, Baltimore, Maryland.

Plumb JD, Brawer RB, Santana A,
Simmons R, Chernett N. Integrating
population health into the fabric of
medical education - College Within the
College. Poster presented at: Teaching
Prevention 2013: Developing Educational
Experiences for and Evolving Healthcare
System, Association for Prevention
Teaching and Research (APTR), March
11, 2013, Washington, DC.

Chernett N. Beat the blues: a tailored
depression intervention for African
American older adults. Presented at:
Eighth National Conference on Quality
Health Care for Culturally Diverse

Simmons R. Plumb J. A global health
framework based on competencies and
learning opportunities in graduate
health education. Presented at:
Association of Teaching Prevention
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and Research (APTR), March 11, 2013,
Washington, DC.
Simmons R. The expanding public health
profession: career opportunities, dual
degree programs and how advisors can
best guide their students. Presented at:
North East Association of Advisors for
the Health Professions, April 12, 2013,
Atlantic City, New Jersey.
Simmons R, Romney M. Training future
and current health promotion leaders:
incorporating policy development and
advocacy into undergraduate, graduate,
and continuing education. Presented
at: Society for Public Health Education
(SOPHE) Annual Meeting, April 19,
2013, Orlando, Florida.

Upcoming Jefferson School of Population Health Forums
May 8, 2013

June 12, 2013

Challenges in Building a KnowledgeBased Technology Infrastructure for
Population Health

Managing Population Health in Low to
Moderate Income Medicare Eligibles

Jonathan M. Niloff, MD

Chief Medical Officer
JenCare
Location: The Curtis Building, Room 218

Chief Medical Officer
MedVentive
Location: Bluemle Life Sciences Building, Room 101

Craig Tanio, MD

Fall 2013 Population Health Forums – SAVE THE DATES
September 11, 2013
October 9, 2013
November 13, 2013
December 11, 2013

All Forums take place from 8:30 am – 9:30 am
For more information call: (215) 955-6969
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